Highly potent API manufacturing is a rapidly growing segment of drug development. Those familiar with HPAPI understand its specialized nature and the strict regulations surrounding it. A complicated and resource-intensive process, sponsors often find themselves in need of knowledgeable outsourcing…
Choosing an outsourcing partner for a commercial bioprocessing endeavor carries a gravitas that those outside that endeavor may not appreciate. Equally significant is the challenge facing CMOs in this space, many of whom are competing against larger, well-known manufacturers with…
I bet you can’t say “cell & gene therapies” three times fast. And by the time you do, you’ll have missed another article on your newsfeed discussing their intricacies and the headaches they can cause. Here’s one from Industry Standard…
ISR’s CTMS Benchmarking & Market Dynamics (3rd Ed.) aims to tackle clinical trial management systems (CTMS) by helping providers and sponsors alike better understand current trends surrounding this technology and anticipate future ones. This report is the result of primary…
How do you ensure the research products and services you buy will make you confident in the decisions you make? Here are six reasons why Industry Standard Research ensures you are getting the value you should expect from quality market…
How Pharma, CROs, and CDMOs can prepare for 2020 ISR conducted approximately two dozen individual pieces of market research for syndication in 2019. This webinar summarizes many of the important learnings from these projects, providing attendees with real, usable data…
Vice President of Market Research at Industry Standard Research Rebecca McAvoy discusses whether the company size of a CRO has an impact on its therapeutic expertise, and by extension, an impact on outsourcing selection. CRO selection. Whether you’ve been in…
Informing pharmaceutical drug developers, manufacturers, and service providers Raleigh, N.C. — October 16, 2018 — Industry Standard Research (ISR) announces the release of its newest report, “Phase I Study Trends and Market Outlook (2018-2022),” in which 143 Phase I decision-makers…
Phase I Outsourcers Value Attributes Like Patient Access Informing pharmaceutical drug developers, manufacturers, and service providers Raleigh, N.C. – September 27, 2018 – Industry Standard Research (ISR) has released a new report, the 10th edition of its CRO Quality Benchmarking…
Informing the drug development and pharmaceutical manufacturing industry. Raleigh, N.C. – September 25, 2018 – Industry Standard Research (ISR) has announced the newest edition of its CRO market analysis report “2018 CRO Market Size Projections: 2017-2022.” For this report, ISR has…
Informing pharmaceutical drug developers, manufacturers, and service providers. Raleigh, N.C. – September 24, 2018 – Industry Standard Research (ISR) has released a new report, the 10th edition of its CRO Quality Benchmarking – Phase IV Service Providers series. ISR surveyed 230 decision-makers at sponsor…
ISR’s latest Biologic API and Biologic Drug Product CDMO Benchmarking Reports have arrived Informing the pharmaceutical drug development, manufacturing and commercialization industry. Raleigh, NC – May 23, 2018 –Industry Standard Research’s (ISR’s) 3rd annual Biologic API Contract Manufacturer Quality Benchmarking…
The 10th Edition of ISR’s Phase II/III CRO Benchmarking has arrived Informing pharmaceutical drug developers, manufacturers, and service providers. Raleigh, N.C. – May 17, 2018 – Industry Standard Research (ISR) has released a new report, the 10th edition of its…
Informing the pharmaceutical drug development, manufacturing and commercialization industry. Cary, NC – May 15, 2018 – Industry Standard Research’s (ISR’s) annual Small Molecule API Contract Manufacturer Quality Benchmarking report reveals that FLAMMA and Novasep received the highest Overall Performance Scores based…
Informing the pharmaceutical drug development, manufacturing and commercialization industry. Cary, NC – August 8, 2017 – Industry Standard Research’s (ISR’s) Small Molecule Sterile Injectable Drug Product Manufacturing Market Overview and Outlook report looks specifically at the portfolios and pipelines of small molecule sterile…
Informing the pharmaceutical drug development, manufacturing and commercialization industry. Cary, NC – July 25, 2017 – Industry Standard Research’s (ISR’s) Development vs Commercial Outsourced Manufacturing Practices: Small Molecule report offers insight into how the industry, using different outsourcing scenarios, prioritizes…
Informing the pharmaceutical drug development, manufacturing and commercialization industry. Cary, NC – July 25, 2017 – Industry Standard Research’s (ISR’s) Development vs Commercial Outsourced Manufacturing Practices: Biologics report offers insight into how respondents in different outsourcing scenarios prioritize different CMO selection…
Informing the pharmaceutical drug development, manufacturing and commercialization industry. CARY, NC – May 31, 2017 – The 2nd edition of Industry Standard Research’s (ISR’s) Oral Dosage Forms Market Overview and Outlook report offers details on how industry utilization rates of seventeen different…
Informing the pharmaceutical drug development, manufacturing and commercialization industry. CARY, NC – May 31, 2017 – Industry Standard Research (ISR) has released a new report, CRO Quality Benchmarking – Phase IV Service Providers (9th Edition), containing findings focused on service provider…
The Phase I CROs received high marks in organization and staff factors Informing the pharmaceutical drug development, manufacturing and commercialization industry. CARY, NC – May 18, 2017 – Industry Standard Research (ISR) has released a new report, CRO Quality Benchmarking – Phase I…
Informing the pharmaceutical drug development, manufacturing and commercialization industry. Cary, N.C. – April 26, 2017 – Industry Standard Research (ISR) has released a new report, CRO Quality Benchmarking – Phase II/III Service Providers (9th Edition), containing findings focused on service…
Informing the pharmaceutical drug development, manufacturing and commercialization industry. Cary, NC – March 7, 2017 – Industry Standard Research (ISR) today announced the release of its latest CRO market report titled; 2017 Edition of the CRO Market Size Projections: 2016-2021….
Manufacturers benefit from having innovators as their parent companies Informing the pharmaceutical drug development, manufacturing and commercialization industry. Cary, NC – February 9, 2017 – The 2nd edition of Industry Standard Research’s (ISR’s) Small Molecule API Contract Manufacturer Quality Benchmarking report…
Informing the pharmaceutical drug development, manufacturing and commercialization industry. Cary, NC – February 8, 2017 – The 2nd edition of Industry Standard Research’s (ISR’s) Drug Product Contract Manufacturer Quality Benchmarking report reveals that buyers of outsourced drug product manufacturing services…
Informing the pharmaceutical drug development, manufacturing and commercialization industry. Cary, NC – February 8, 2017 – The 2nd edition of Industry Standard Research’s (ISR’s) Biologic API Contract Manufacturer Quality Benchmarking report indicates that buyers of outsourced biologic API services are…
Informing the pharmaceutical drug development, manufacturing and commercialization industry. Cary, NC – November 18, 2016 – A new market research report from Industry Standard Research (ISR), Contract Development and Manufacturing Outsourcing Models, reveals the motivations and strategies behind drug innovators’…
Informing the pharmaceutical drug development, manufacturing and commercialization industry on eTMF software providers. Cary, NC – October 27, 2016 – Industry Standard Research has announced the release of their report “eTMF Market and Service Provider Dynamics.” This report gives eTMF…
New report defines which biologic manufacturing capabilities are needed Informing the pharmaceutical drug development, manufacturing and commercialization industry. Cary, NC – October 12, 2016 – A new report from Industry Standard Research (ISR), Bioprocessing Services and Technologies Market Trends and…
Informing the pharmaceutical drug development, manufacturing and commercialization industry. Cary, NC – August 30, 2016 – A new report, Best Practices in Study Feasibility, from Industry Standard Research (ISR) reveals insights into how to successfully navigate many of the challenges—medical,…
Informing the pharmaceutical drug development, manufacturing and commercialization industry. Cary, NC – August 16, 2016 – A new report from Industry Standard Research (ISR), Best Practices in Patient Recruitment, shows that Sponsors and CROs agree, hiring a specialized patient recruitment…
Informing the pharmaceutical drug development, manufacturing and commercialization industry. Cary, NC – July 19, 2016 – Industry Standard Research has released a new report, Late Phase Study Trends and Market Outlook (2016-2020), containing findings focused on current dynamics in the…
Informing the pharmaceutical drug development, manufacturing and commercialization industry. Cary, NC – June 21, 2016 – Industry Standard Research has released its comprehensive new report, “Phase II/III Study Trends and Market Outlook (2016-2020),” concerning the trends, resource allocation, and market…
Informing the pharmaceutical drug development, manufacturing and commercialization industry. Cary, NC – May 17, 2016 – A new report titled Biosimilars Manufacturing: Key Considerations and Expected Outsourcing Practices (3rd edition), from Industry Standard Research (ISR), indicates that the majority of…
Informing the pharmaceutical drug development, manufacturing and commercialization industry. Cary, NC – March 29, 2016 – Industry Standard Research (ISR) today announced a new addition to its Department Models and Structures suite of reports. The new report aims to provide…
Informing the pharmaceutical drug development, manufacturing and commercialization industry Cary, NC – February 2, 2016 – Industry Standard Research (ISR) today announced a new addition to its Market Analysis suite of reports. The “2016 Edition of the CRO Market Size…
Cary, NC – January 12, 2016 – Industry Standard Research (ISR) today announced the addition of three reports to its Contract Manufacturer Quality Benchmarking suite of reports to provide readers a comprehensive assessment of biopharmaceutical CMO service quality across three…
Cary, N.C. – November 17, 2015 – Industry Standard Research (ISR) is announcing the availability of a new report titled Clinical Development Outsourcing Models (2nd edition). This report reveals sponsors’ satisfaction and preferences with seven different outsourcing models, their reasons…
Cary, N.C. – June 9, 2015 – Industry Standard Research (ISR) today announced the availability of the “Contract Manufacturer Quality Benchmarking (2015)” report, providing a comprehensive assessment of CMO service quality. This report provides a Consumer Reports-style analysis of CMO…
The most comprehensive assessment of CRO service quality in the industry Informing the drug development and commercialization industry Cary, N.C. – May 6, 2015 – Industry Standard Research (ISR) has announced the availability of its 7th annual CRO Quality Benchmarking…
Informing the drug development and commercialization industry Cary, N.C. – January 28, 2015 – Industry Standard Research (ISR) has announced the availability of a new report titled, “CRO Quality Benchmarking – Preclinical Service Providers.” This report provides a Consumer Reports-style…
Informing the drug development and commercialization industry Cary, N.C. – June 11, 2014 – Industry Standard Research (ISR) today announced the release of their “CRO Quality Benchmarking – Phase I Service Providers” report. This research, based on in-depth surveys collected…
Informing the pharmaceutical drug development and commercialization industry Cary, N.C. – April 15, 2014 – Industry Standard Research (ISR) is announcing the release of its latest report entitled “Bladder Cancer: Disease and Pipeline Analysis.” This report provides an overview of…
Informing the Pharmaceutical Drug Development and Commercialization Industry. Cary, N.C. – March 19, 2014 – Industry Standard Research (ISR) is announcing the launch of its 6th annual CRO Quality Benchmarking series with today’s release of its “CRO Quality Benchmarking – Phase II/III…
Informing the pharmaceutical drug development and commercialization industry. Cary, N.C. – March 12, 2014 – Industry Standard Research (ISR) today announced the availability of a new report titled “Contract Manufacturer Quality Benchmarking (2014),” providing a comprehensive assessment of CMO service…
Informing the pharmaceutical drug development and commercialization industry. Cary, N.C. – March 5, 2013 – Industry Standard Research (ISR) has announced the release of a new market research report titled “Headaches: Current Treatments, Unmet Needs, and Patient Recruitment.” This report…
Informing the pharmaceutical drug development and commercialization industry. Cary, N.C. – January 7, 2013 – Industry Standard Research (ISR) has announced the release of a new market research report entitled “Autoimmune Diseases: Current Treatments, Unmet Needs, and Patient Recruitment.” This…
Informing the drug development and commercialization industry Cary, N.C. – August 23, 2013 – Industry Standard Research (ISR) today announced the availability of a new report titled “2013 CRO Quality Benchmarking – Phase I Service Providers” providing the most comprehensive…
Informing the drug development and commercialization industry Cary, N.C. – June 20, 2013 – Industry Standard Research (ISR) today announced the release of a new market research report titled “EMRs and Clinical Research: Current and Potential Impact.” This report provides…
Informing the drug development and commercialization industry Cary, N.C. – May 29, 2012 – Industry Standard Research (ISR) today announced the release of a new market research report titled “EDC and ePRO Market Trends and Service Provider Performance.” This report…
Informing the drug development and commercialization industry Cary, N.C. – May 15, 2012 – Industry Standard Research (ISR) today announced the release of a new market research report titled “2013 Phase I Study Trends and Market Outlook” providing the pharmaceutical…
Informing the drug development and commercialization industry Cary, N.C. – May 9, 2013 – Industry Standard Research (ISR) released a new market research report today entitled “Risk-based Monitoring: Industry Guidance on Adoption, Use, and Outsourcing.” The report was developed by…
Informing the drug development and commercialization industry Cary, N.C. – April 23, 2012 – Industry Standard Research (ISR) announced the launch of its 5th annual CRO Quality Benchmarking series with today’s release of its “2013 CRO Quality Benchmarking – Phase…
Informing the drug development and commercialization industry Cary, N.C. – February 20, 2013 – Industry Standard Research (ISR) today announced the release of a new market report titled “2013 Late Phase Market Overview and Outlook” which provides the pharmaceutical industry…
Informing the drug development and commercialization industry. Cary, N.C. – January 8, 2013 – Industry Standard Research (ISR) today announced the release of a new market research report titled “Social Media: Best Practices and Strategic Use in Patient Recruitment,” which…
Informing the pharmaceutical and biotech industry. Cary, N.C. – October 30, 2012 – Industry Standard Research (ISR) today announced the availability of their newest report, “Benchmarking Investigator Payments,” which analyzes the level of compensation investigative sites receive for participation in…
Informing the pharmaceutical and biotech industry. Cary, N.C. – October 9, 2012 – Industry Standard Research (ISR) today announced the availability of their latest report, “Hepatitis C: Social Media, Search, and Market Analysis,” providing a product and pipeline analysis of…
Informing the pharmaceutical and biotech industry. Cary, N.C. – September 18, 2012 – Industry Standard Research (ISR) today announced the availability of their newest CRO Benchmarking report, 2012 CRO Quality Benchmarking – Phase IV Service Providers, which provides service quality…
Informing the drug development and commercialization industry Cary, N.C. – July 19, 2012 – Industry Standard Research (ISR) today announced the availability of a new report titled 2012 CRO Quality Benchmarking – Phase I Service Providers, which provides service quality…
Informing the drug development and commercialization industry Cary, N.C. – June 18, 2012 – Industry Standard Research (ISR) today announced the launch of a new market research report titled “MSL and Sales Strategies for the US Oncology Market”, which provides…
Informing the drug development and commercialization industry Cary, N.C. – May 23, 2012 – Industry Standard Research (ISR) today announced the launch of a new market research report titled “Optimizing Investigator Recruitment in Clinical Trials” that provides recruitment professionals with…
Informing the drug development and commercialization industry Cary, N.C. – May 2, 2012 – Industry Standard Research (ISR) today announced the availability of a new report titled “Optimizing Patient Recruitment in Clinical Trials” that provides sponsors and service providers with…
Informing the drug development and commercialization industry Cary, N.C. – February 26, 2012 – Industry Standard Research (ISR) today announced the release of a new pharmaceutical market research report entitled “Sunshine Act: Pharma Impact – Changes in US Physician Behavior,”…
Informing the Drug Development and Commercialization Industry Cary, N.C. – January 17, 2012 – Industry Standard Research (ISR) today announced the release of a new report focused on the impact comparative effectiveness research (CER) is and will have on formulary…
Cary, N.C. – January 4, 2012 – Industry Standard Research (ISR) today announced the release of a new report titled “Clinical Imaging Market Dynamics and Service Provider Performance” in which 36 pharmaceutical sponsor decision-makers provide their usage, insights, and forecasts…
Informing the Drug Development and Commercialization Industry Cary, N.C. – December 13, 2011 – Industry Standard Research (ISR) today announced the release of a new report titled “Cardiac Safety / ECG Market Dynamics and Service Provider Performance” in which 79…
Cary, N.C. – September 19, 2011 – Industry Standard Research (ISR) today announced the release of an important piece of research, this one profiling the post-marketing safety industry. ISR’s new “Post-marketing Safety Market Overview and Outlook” report provides pharmaceutical companies…
Cary, N.C. – August 16, 2011 – Industry Standard Research (ISR) today announced the release of their “2011 Phase I Market Overview and Outlook” report, in which 104 pharmaceutical decision makers responsible for Phase I activities provide valuable insight into…
Cary, N.C. – June 13, 2011 – Industry Standard Research (ISR) today announced the availability of its 3rd annual CRO Quality Benchmarking Report. The 2011 version of the report profiles 169 pharmaceutical and biotechnology professionals and their experiences with dozens…
Cary, N.C. – May 17, 2011 – Industry Standard Research (ISR) today announced the launch of a new and substantial research report titled “EDC and ePRO Market Overview and Outlook.” This report presents data and analysis from 107 interviews with…
Cary, N.C. – November 15, 2010 – Industry Standard Research (ISR) today announced the launch of a new and substantial research report titled “Improving Patient Recruitment and Feasibility: Recommendations from Site Coordinators.” This report presents data and analysis from 124…
Cary, N.C. – June 28, 2010 – Industry Standard Research (ISR) today announced the release of The State of Biomarkers in Drug Development report. 44 pharmaceutical and biotechnology professionals provided their strategies, insights, and predictions in this snapshot of a…
Cary, N.C. – April 19, 2010 – Industry Standard Research (ISR Reports) today announced the launch of the 2010 Edition of the CRO Quality Benchmarking Report. 150 pharmaceutical and biotechnology professionals provided their experiences with dozens of small, mid-size and…
Cary, N.C. – March 17, 2010 – Industry Standard Research (ISR Reports) today announced the launch of a new and substantial research report titled Late Phase Market Overview and Outlook. This report presents data and analysis from 149 interviews with…
© 2026 ISR Market Research. All rights reserved.